Please use this identifier to cite or link to this item:
Title: First-line combination therapy versus first-line monotherapy for primary hypertension.
Issue Date: 2017
Citation: Cochrane Database Syst Rev.2017 01;(1):CD010316
Abstract: Starting with one drug and starting with a combination of two drugs are strategies suggested in clinical guidelines as initial treatment of hypertension. The recommendations are not based on evidence about clinically relevant outcomes. Some antihypertensive combinations have been shown to be harmful. The actual harm-to-benefit balance of each strategy is unknown.
PMID: 28084624
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos

Files in This Item:
File Description SizeFormat 
PMC6464906.pdf630.48 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.